Abstract:BACKGROUNDChronic obstructive pulmonary disease (COPD) is characterized by chronic bronchitic and emphysematous components. In one biophysical model, the concentration of mucin on the airway surfaces is hypothesized to be a key variable that controls mucus transport in healthy persons versus cessation of transport in persons with muco-obstructive lung diseases. Under this model, it is postulated that a high mucin concentration produces the sputum and disease progression that are characteristic of chronic bronchitis.METHODSWe characterized the COPD status of 917 participants from the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) using questionnaires administered to participants, chest tomography, spirometry, and examination of induced sputum. Total mucin concentrations in sputum were measured with the use of size-exclusion chromatography and refractometry. In 148 of these participants, the respiratory secreted mucins MUC5AC and MUC5B were quantitated by means of mass spectrometry. Data from chronic-bronchitis questionnaires and data on total mucin concentrations in sputum were also analyzed in an independent 94-participant cohort.RESULTSMean (+/- SE) total mucin concentrations were higher in current or former smokers with severe COPD than in controls who had never smoked (3166 +/- 402 vs. 1515 +/- 152 mu g per milliliter) and were higher in participants with two or more respiratory exacerbations per year than in those with zero exacerbations (4194 +/- 878 vs. 2458 +/- 113 mu g per milliliter). The absolute concentrations of MUC5B and MUC5AC in current or former smokers with severe COPD were approximately 3 times as high and 10 times as high, respectively, as in controls who had never smoked. Receiver-operating-characteristic curve analysis of the association between total mucin concentration and a diagnosis of chronic bronchitis yielded areas under the curve of 0.72 (95% confidence interval [CI], 0.65 to 0.79) for the SPIROMICS cohort and 0.82 (95% CI, 0.73 to 0.92) for the independent cohort.CONCLUSIONSAirway mucin concentrations may quantitate a key component of the chronic bronchitis pathophysiologic cascade that produces sputum and mediates disease severity. Studies designed to explore total mucin concentrations in sputum as a diagnostic biomarker and therapeutic target for chronic bronchitis appear to be warranted. (Funded by the National Heart, Lung, and Blood Institute and others.)

Sputum rheology critical stress is associated with non-cystic fibrosis bronchiectasis severity

Small-airway Dysfunction among Non-Cystic Bronchiectasis Patients with Different Bronchiectasis Severity Index

Correlation of sputum inflammatory markers with severity and blood inflammatory markers in bronchiectasis

Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

Airway Microbiota is Associated with the Severity of Non‐cf Bronchiectasis

Correlation between Air-trapping and Severity of Dyspnea in Non-Cystic Fibrosis Bronchiectasis

Impact of saline solutions nebulisation on the biophysical properties of sputum in bronchiectasis

The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis

Sputum neutrophil elastase in bronchiectasis: a Southern European cohort study

Total sputum nitrate/nitrite is associated with exacerbations and Pseudomonas aeruginosa colonisation in bronchiectasis

Airway Mucin Concentration As a Marker of Chronic Bronchitis

The Value of Fractional Exhaled Nitric Oxide and Forced Mid-Expiratory Flow As Predictive Markers of Bronchial Hyperresponsiveness in Adults with Chronic Cough.

Microbiology sampling in non-cystic fibrosis bronchiectasis cases from northern Alberta

Investigation of immune dysregulation in bronchiectasis: alterations of myeloid-derived suppressor cells and regulatory T cells

Potential effect of pulmonary fluid viscosity on positive end-expiratory pressure and regional distribution of lung ventilation in acute respiratory distress syndrome

Quantitative CT measures are sensitive to clinical bronchiectasis severity: preliminary data from the BRILLIANT study

Association between lung function impairment and inflammatory cytokines in induced sputum of patients with bronchiectasis

Sputum Eosinophilia and Magnetic Resonance Imaging Ventilation Heterogeneity in Severe Asthma

Nanoparticle diffusion in spontaneously expectorated sputum as a biophysical tool to probe disease severity in COPD

Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases

Sputum neutrophil elastase associates with microbiota and Pseudomonas aeruginosa in bronchiectasis